Papp, Kim
-
SKIN The Journal of Cutaneous Medicine Vol. 4 No. 6 (2020): November Issue & Poster Presentations (FC20 Dermatology Conference®) - Atopic Dermatitis
Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From Two Phase 3, Randomized, Double-Blind Studies
Abstract Poster PDF -
SKIN The Journal of Cutaneous Medicine Vol. 5 No. 1 (2021): January Issue & Poster Presentations (WC21 Dermatology Conference®) - Atopic Dermatitis
Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Pooled Analysis of Two Phase 3, Randomized, Double-Blind Studies
Abstract Poster PDF -
SKIN The Journal of Cutaneous Medicine Vol. 2 (2018): Supplemental Issue: Scientific Posters Presented at 2018 Winter Clinical Dermatology Conference®-Hawaii - Psoriasis
Clinical Efficacy or Tildrakizumab in Patients with Chronic Plaque Psoriasis Over 2 Years of Treatment: Results from Long-Term Extensions to 2 Phase 3 Clinical Studies
Abstract Poster PDF -
SKIN The Journal of Cutaneous Medicine Vol. 1 (2017): Supplemental Issue: Scientific Posters Presented at 2017 Fall Clinical Dermatology Conference®-Las Vegas - Rosacea
Concurrent Administration of Ivermectin 1% Cream with Brimonidine 0.33% Gel Improves Efficacy and Tolerability in the Treatment of Moderate-to-Severe Rosacea
Abstract Poster PDF -
SKIN The Journal of Cutaneous Medicine Vol. 4 No. 5 (2020): September Issue & Poster Presentations (FCPANP20® Dermatology Conference) - Poster Presentations from FCPANP20 Clinical Conference®: Psoriasis
BMS-986165, an Oral, Selective Tyrosine Kinase 2 (TYK2) Inhibitor: Evaluation of Changes in Laboratory Parameters in Response to Treatment in a Phase 2 Trial in Psoriasis Patients
Abstract Poster PDF -
SKIN The Journal of Cutaneous Medicine Vol. 4 No. 6 (2020): November Issue & Poster Presentations (FC20 Dermatology Conference®) - Poster Presentations from FC20 Clinical Dermatology Conference®: Psoriasis
Roflumilast Cream (ARQ-151) 0.15% and 0.3% Improved Burden of Signs and Symptoms in Adults With Chronic Plaque Psoriasis in a Phase 2b Study
Abstract Poster PDF -
SKIN The Journal of Cutaneous Medicine Vol. 4 No. 6 (2020): November Issue & Poster Presentations (FC20 Dermatology Conference®) - Poster Presentations from FC20 Clinical Dermatology Conference®: Psoriasis
Roflumilast Cream (ARQ-151) Improved Itch Severity and Itch-Related Sleep Loss in Adults With Chronic Plaque Psoriasis in a Phase 2b Study
Abstract Poster PDF -
SKIN The Journal of Cutaneous Medicine Vol. 3 (2019): Supplemental Issue: Scientific Posters Presented at 2019 Fall Clinical Dermatology Conference®-Las Vegas - Psoriasis
Long-term Efficacy, Safety, and Patient-Reported Outcomes in a Phase 2 Study of Brodalumab
Abstract Poster PDF